Abstract | PURPOSE OF REVIEW:
Homocystinuria is a congenital metabolic disorder in which cystathionine β-synthase deficiency results in a prominent increase in homocysteine (serum levels > 100 μM), causing mental retardation, atherosclerotic cerebral infarction, and osteoporosis accompanied by fragility fractures. Encountering a case with excessive homocysteinemia such as that seen in hereditary homocystinuria is unlikely during usual medical examinations. However, in individuals who have vitamin B or folate deficiency, serum homocysteine concentrations are known to increase. These individuals may also have a polymorphism in methylenetetrahydrofolate reductase, MTHFR (C677T: TT type), which regulates homocysteine metabolism. These changes in homocysteine levels may elicit symptoms resembling those of homocystinuria (e.g., Alzheimer's disease, atherosclerosis, osteoporosis). RECENT FINDINGS:
|
Authors | Mitsuru Saito, Keishi Marumo |
Journal | Current osteoporosis reports
(Curr Osteoporos Rep)
Vol. 16
Issue 5
Pg. 554-560
(10 2018)
ISSN: 1544-2241 [Electronic] United States |
PMID | 30116976
(Publication Type: Journal Article, Review)
|
Chemical References |
- Glycation End Products, Advanced
- Homocysteine
- Collagen
- MTHFR protein, human
- Methylenetetrahydrofolate Reductase (NADPH2)
|
Topics |
- Bone and Bones
(metabolism)
- Collagen
(metabolism)
- Folic Acid Deficiency
(metabolism)
- Glycation End Products, Advanced
(metabolism)
- Homocysteine
(metabolism)
- Homocystinuria
(complications, genetics, metabolism)
- Humans
- Hyperhomocysteinemia
(complications, metabolism)
- Methylenetetrahydrofolate Reductase (NADPH2)
(deficiency, genetics, metabolism)
- Muscle Spasticity
(complications, genetics, metabolism)
- Osteoblasts
(metabolism)
- Osteoclasts
(metabolism)
- Osteoporosis
(etiology, metabolism)
- Polymorphism, Genetic
- Psychotic Disorders
(complications, genetics, metabolism)
- Vitamin B Deficiency
(metabolism)
|